Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Cemiplimab Plus Gemcitabine in Patients With Metastatic Pancreatic Adenocarcinoma

University of California, San Diego · 2026
ClinicalTrials.gov · Datasets · License: Public Domain · 2026
Open Source ↗
immune-checkpoint-inhibitorspancreatic-ductal-adenocarcinoma
pancreatic ductal adenocarcinoma (mpdac), cemiplimab, gemcitabine, immune checkpoint inhibitors, pancreatic ductal adenocarcinoma, swi/snf, combination therapy, pdac, phase 2, metastatic, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 911900
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.